These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33239161)

  • 1. Novel biomarkers in the prognosis of patients with atherosclerotic coronary artery disease.
    Freitas IA; Lima NA; Silva GBD; Castro RL; Patel P; Lima CCV; Lino DODC
    Rev Port Cardiol (Engl Ed); 2020 Nov; 39(11):667-672. PubMed ID: 33239161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
    Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
    Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
    Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
    PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
    Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive role of neutrophil gelatinase-associated lipocalin in coronary artery disease.
    Wang Q; Yang J; Guo Z; Xi D
    Am J Med Sci; 2024 Nov; 368(5):424-431. PubMed ID: 38906376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.
    ErŽen B; Šilar M; Šabovič M
    BMC Cardiovasc Disord; 2014 Nov; 14():166. PubMed ID: 25417001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
    Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.
    Dong L; Ma Q; Bennett M; Devarajan P
    Pediatr Nephrol; 2017 Dec; 32(12):2351-2360. PubMed ID: 28755073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).
    Brankovic M; Akkerhuis KM; Buljubasic N; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Regar E; Serruys PW; van Geuns RJ; Boersma E; Kardys I
    Atherosclerosis; 2016 Nov; 254():20-27. PubMed ID: 27680774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging families of biomarkers for coronary artery disease: inflammatory mediators.
    Yayan J
    Vasc Health Risk Manag; 2013; 9():435-56. PubMed ID: 23983474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
    Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
    Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: A novel approach to disease diagnosis of stable CAD and acute coronary syndrome.
    Parizadeh SM; Ferns GA; Ghandehari M; Hassanian SM; Ghayour-Mobarhan M; Parizadeh SMR; Avan A
    J Cell Physiol; 2018 Sep; 233(9):6418-6424. PubMed ID: 29215707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will urinary biomarkers provide a breakthrough in diagnosing cardiac surgery-associated AKI? - A systematic review.
    Hussain ML; Hamid PF; Chakane N
    Biomarkers; 2020 Jul; 25(5):375-383. PubMed ID: 32479185
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.
    Winkel P; Jakobsen JC; Hilden J; Jensen GB; Kjøller E; Sajadieh A; Kastrup J; Kolmos HJ; Iversen KK; Bjerre M; Larsson A; Ärnlöv J; Gluud C
    BMJ Open; 2020 Aug; 10(8):e033720. PubMed ID: 32819979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.
    Hemdahl AL; Gabrielsen A; Zhu C; Eriksson P; Hedin U; Kastrup J; Thorén P; Hansson GK
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):136-42. PubMed ID: 16254208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.